Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up 101 News Items found MSK Research Led to FDA Approvals for Cancer Drugs in 2024 Friday, June 6, 2025 The U.S. Food and Drug Administration (FDA) approved 11 cancer drugs in 2024 based on significant contributions from MSK researchers. Announcement Respected Physician and Researcher George J. Bosl Named Memorial Sloan Kettering's First Ombudsperson, a Confidential Resource for Staff Friday, July 5, 2019 Learn about George Bosl, who will become MSK's first ombudsperson. Feature Beyond the Surface: MSK’s Dental Service Aims to Make People Whole Again Wednesday, July 12, 2017 A vital part of MSK's mission is to get patients back to feeling like themselves. In the Lab Escape Artists: Cancer Cells Mimic Immune Cell Activity to Spread Wednesday, January 17, 2018 Researchers have discovered that cancer cells may hijack an immune response to spread from a primary tumor to distant organs. Top Cancer Treatment Advances at MSK in 2024 Tuesday, December 17, 2024 Learn about some of the most important advances in cancer treatment and clinical trials at MSK in 2024. Throat Cancer Treatment at MSK, Thanks to an Employer’s Cancer Care Benefits Friday, March 28, 2025 Learn how MSK Direct — one of the nation's largest employer cancer benefits programs — made it easier for Steve Harrold to travel from Massachusetts to MSK for treatment days after a throat cancer diagnosis. Science Byte Breaking Bad: Researchers Find Mutations that Turn Thyroid Cancers Deadly Tuesday, August 8, 2017 MSK researchers identify mutations that convert nonthreatening thyroid tumors into aggressive cancers. Feature Your Gut Microbiome: How To Improve It, Its Effects on the Immune System, and More Thursday, June 8, 2023 This story answers common questions about how your gut microbiota impacts your health, how to protect it, and the impact it has on diseases like cancer. Why New Precision Oncology Cancer Treatments Benefit Patients of Some Ancestries More Than Others Thursday, January 9, 2025 Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ancestries, according to new MSK research. This trend could exacerbate disparities in cancer outcomes. Finding Tumor Mutational Burden Can Help Predict Response to Immunotherapy in Many Different Cancers Thursday, January 17, 2019 Investigators confirmed that people whose tumors have a high tumor mutational burden and were treated with immunotherapy lived longer. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last » Book traversal links for Newsroom Previous Newsroom Next Cancer Vaccine Could Prevent Neuroblastoma From Returning After Antibody Treatment